Serialisation expert, Christoph Krähenbühl, 3C Integrity, deconstructs the final draft Delegated Act to summarise the key actions required by pharma manufacturers in implementing serialisation programmes
The poor old pumpkin gets a rough ride. Every year millions of us take to it with a carving knife, hacking gruesome grimaces into this much maligned veg and then pop a red-hot hot light inside it. Who’d be a pumpkin eh?
In a few years you may be forgiven for thinking that the face of healthcare – of which the pharma sector plays an increasingly significant role – has mutated into an episode of Doctor Who.
Robert Gaertner, director strategy, Veeva QualityDocs Europe, looks at the way that digitisation has changed life sciences and what the future holds, including technology development and upcoming regulatory requirements
Noxilizer’s Evan Goulet and Stephen Morley outline the advantages that nitrogen dioxide (NO2) technology is able to provide over more traditional methods in the sterilisation of prefilled syringes
Jörg Gierds, Fette Compacting looks at the rising demands on tablet presses for highly potent agents and explains how efficiency can be achieved through seamless containment
The solution to Anti-Microbial Resistance (AMR) is widely thought to lie in the development of new antibiotics and diagnostic tests however Helen Lambert disagrees
Crawford Healthcare’s Richard Anderson discusses how new approaches to antimicrobial resistance and silver-based wound dressings could relieve the burden on the NHS
The European Federation of Pharmaceutical Industries and Associations discusses the importance of its Partners in Research initiative to boost research in healthcare
